NCT06546553
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06546553
Title A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
Florida Cancer Specialists Orlando Florida 32827 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists Orlando Florida 32827 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
START San Antonio San Antonio Texas 78229 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field